S&P Futures
4,561.25 -10.00 (-0.22%) Dow Futures
35,197.00 -62.00 (-0.18%) Nasdaq Futures
15,160.25 -45.75 (-0.30%) Russell 2000 Futures
2,083.30 -8.80 (-0.42%) Crude Oil
85.86 +0.43 (+0.50%) Gold
1,815.10 +2.70 (+0.15%)
Xenetic Biosciences, Inc. (XBIO)
After hours:
- ACCESSWIRE
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
\- Access the event and schedule of presenting companies at virtualinvestorco.com -\- Live video webcast presentations of participating companies followed by interactive Q&A session -PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 /JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2022 Top Picks Conference January 25-27, 2022.
- ACCESSWIRE
Xenetic Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
* Company advancing XCARTTM pre-clinical development plan toward IND-enabling studies * Strengthened cash position to fund operations through XCART IND filing with recently completed $12.5 million private placement * Continued royalty stream growth through license agreement with PolyXen® platform technologyFRAMINGHAM, MA / ACCESSWIRE / November 12, 2021 / Xenetic Biosciences, Inc.
- Zacks
Analysts Estimate Xenetic Biosciences (XBIO) to Report a Decline in Earnings: What to Look Out for
Xenetic Biosciences (XBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
